Sutro Biopharma IncNASDAQ:STRO
- LAST PRICE3.7600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 3.7600
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STRO |
|---|---|---|
| 09:32 ET | 7414 | 3.97 |
| 09:34 ET | 8984 | 3.93 |
| 09:36 ET | 17819 | 3.91 |
| 09:38 ET | 1237 | 3.897 |
| 09:39 ET | 14988 | 3.93 |
| 09:41 ET | 5082 | 3.95 |
| 09:43 ET | 1974 | 3.94 |
| 09:45 ET | 3900 | 3.92 |
| 09:48 ET | 5030 | 3.92 |
| 09:50 ET | 8211 | 3.91 |
| 09:52 ET | 6037 | 3.9 |
| 09:54 ET | 2190 | 3.905 |
| 09:56 ET | 309 | 3.92 |
| 09:57 ET | 200 | 3.925 |
| 09:59 ET | 454 | 3.93 |
| 10:01 ET | 27550 | 3.905 |
| 10:03 ET | 7436 | 3.955 |
| 10:06 ET | 3896 | 3.955 |
| 10:08 ET | 900 | 3.9501 |
| 10:10 ET | 600 | 3.955 |
| 10:12 ET | 2305 | 3.9394 |
| 10:14 ET | 398 | 3.95 |
| 10:15 ET | 849 | 3.935 |
| 10:17 ET | 27073 | 3.865 |
| 10:19 ET | 2505 | 3.84 |
| 10:21 ET | 1862 | 3.83 |
| 10:24 ET | 1100 | 3.84 |
| 10:26 ET | 1885 | 3.8198 |
| 10:28 ET | 8870 | 3.83 |
| 10:30 ET | 343 | 3.82 |
| 10:32 ET | 200 | 3.8198 |
| 10:33 ET | 8043 | 3.83 |
| 10:35 ET | 1100 | 3.84 |
| 10:37 ET | 1503 | 3.845 |
| 10:39 ET | 912 | 3.85 |
| 10:42 ET | 100 | 3.845 |
| 10:44 ET | 100 | 3.845 |
| 10:46 ET | 600 | 3.845 |
| 10:50 ET | 1655 | 3.835 |
| 10:51 ET | 2429 | 3.82 |
| 10:53 ET | 1247 | 3.825 |
| 10:55 ET | 2714 | 3.825 |
| 10:57 ET | 639 | 3.83 |
| 11:00 ET | 1200 | 3.835 |
| 11:02 ET | 300 | 3.86 |
| 11:04 ET | 1430 | 3.85 |
| 11:06 ET | 1000 | 3.8722 |
| 11:09 ET | 5849 | 3.89 |
| 11:11 ET | 1358 | 3.88 |
| 11:13 ET | 300 | 3.88 |
| 11:15 ET | 1990 | 3.89 |
| 11:18 ET | 100 | 3.895 |
| 11:20 ET | 200 | 3.905 |
| 11:22 ET | 5500 | 3.905 |
| 11:24 ET | 100 | 3.905 |
| 11:26 ET | 3315 | 3.9194 |
| 11:27 ET | 585 | 3.91 |
| 11:29 ET | 1000 | 3.91 |
| 11:31 ET | 100 | 3.9 |
| 11:33 ET | 21254 | 3.9301 |
| 11:36 ET | 3470 | 3.915 |
| 11:38 ET | 1400 | 3.905 |
| 11:40 ET | 100 | 3.91 |
| 11:42 ET | 100 | 3.915 |
| 11:47 ET | 1654 | 3.905 |
| 11:49 ET | 400 | 3.905 |
| 11:51 ET | 1300 | 3.915 |
| 11:56 ET | 997 | 3.92 |
| 11:58 ET | 1276 | 3.91 |
| 12:00 ET | 300 | 3.9009 |
| 12:02 ET | 1492 | 3.915 |
| 12:05 ET | 6247 | 3.875 |
| 12:07 ET | 225 | 3.875 |
| 12:09 ET | 100 | 3.878 |
| 12:12 ET | 1722 | 3.86 |
| 12:16 ET | 100 | 3.8505 |
| 12:20 ET | 500 | 3.855 |
| 12:21 ET | 4998 | 3.8501 |
| 12:23 ET | 100 | 3.855 |
| 12:25 ET | 4010 | 3.85 |
| 12:27 ET | 1300 | 3.8403 |
| 12:30 ET | 19013 | 3.8499 |
| 12:32 ET | 18032 | 3.825 |
| 12:34 ET | 2850 | 3.8306 |
| 12:38 ET | 1486 | 3.82 |
| 12:39 ET | 6500 | 3.83 |
| 12:43 ET | 100 | 3.83 |
| 12:45 ET | 3481 | 3.8301 |
| 12:48 ET | 894 | 3.83 |
| 12:50 ET | 100 | 3.825 |
| 12:52 ET | 400 | 3.83 |
| 12:54 ET | 1500 | 3.8354 |
| 12:59 ET | 3448 | 3.835 |
| 01:01 ET | 400 | 3.84 |
| 01:03 ET | 300 | 3.845 |
| 01:08 ET | 2251 | 3.835 |
| 01:10 ET | 1120 | 3.836 |
| 01:12 ET | 1000 | 3.84 |
| 01:14 ET | 8146 | 3.83 |
| 01:15 ET | 1443 | 3.83 |
| 01:17 ET | 3426 | 3.84 |
| 01:19 ET | 100 | 3.835 |
| 01:21 ET | 7994 | 3.86 |
| 01:24 ET | 1800 | 3.865 |
| 01:26 ET | 300 | 3.87 |
| 01:28 ET | 100 | 3.875 |
| 01:30 ET | 311 | 3.875 |
| 01:32 ET | 3198 | 3.875 |
| 01:33 ET | 3250 | 3.88 |
| 01:37 ET | 1400 | 3.895 |
| 01:39 ET | 100 | 3.895 |
| 01:42 ET | 1090 | 3.8962 |
| 01:44 ET | 3592 | 3.8994 |
| 01:46 ET | 562 | 3.9 |
| 01:48 ET | 200 | 3.905 |
| 01:50 ET | 2497 | 3.885 |
| 01:55 ET | 1900 | 3.885 |
| 01:57 ET | 1813 | 3.87 |
| 02:06 ET | 3366 | 3.85 |
| 02:08 ET | 771 | 3.85 |
| 02:09 ET | 1303 | 3.8299 |
| 02:11 ET | 800 | 3.83 |
| 02:13 ET | 100 | 3.835 |
| 02:20 ET | 100 | 3.835 |
| 02:22 ET | 100 | 3.835 |
| 02:26 ET | 2554 | 3.84 |
| 02:27 ET | 100 | 3.84 |
| 02:29 ET | 200 | 3.845 |
| 02:33 ET | 990 | 3.85 |
| 02:36 ET | 342 | 3.8401 |
| 02:38 ET | 6671 | 3.83 |
| 02:40 ET | 300 | 3.83 |
| 02:42 ET | 100 | 3.835 |
| 02:44 ET | 2500 | 3.83 |
| 02:45 ET | 650 | 3.8201 |
| 02:47 ET | 460 | 3.825 |
| 02:49 ET | 400 | 3.8291 |
| 02:51 ET | 2700 | 3.835 |
| 02:54 ET | 350 | 3.835 |
| 02:56 ET | 100 | 3.835 |
| 02:58 ET | 591 | 3.83 |
| 03:00 ET | 8349 | 3.85 |
| 03:02 ET | 1550 | 3.84 |
| 03:03 ET | 679 | 3.8297 |
| 03:05 ET | 4161 | 3.84 |
| 03:07 ET | 500 | 3.835 |
| 03:09 ET | 200 | 3.835 |
| 03:12 ET | 500 | 3.835 |
| 03:14 ET | 1136 | 3.83 |
| 03:18 ET | 1050 | 3.835 |
| 03:20 ET | 100 | 3.83 |
| 03:21 ET | 11407 | 3.8 |
| 03:23 ET | 14332 | 3.785 |
| 03:25 ET | 11492 | 3.785 |
| 03:27 ET | 690 | 3.785 |
| 03:30 ET | 2000 | 3.785 |
| 03:32 ET | 2450 | 3.785 |
| 03:34 ET | 1600 | 3.795 |
| 03:36 ET | 1778 | 3.79 |
| 03:39 ET | 3574 | 3.79 |
| 03:43 ET | 3200 | 3.7901 |
| 03:45 ET | 1836 | 3.785 |
| 03:48 ET | 231 | 3.78 |
| 03:50 ET | 9784 | 3.79 |
| 03:52 ET | 647 | 3.79 |
| 03:54 ET | 4634 | 3.8 |
| 03:56 ET | 1547 | 3.795 |
| 03:57 ET | 8663 | 3.785 |
| 03:59 ET | 5899 | 3.76 |
May 15, 2024
DJ Sutro Biopharma Is Maintained at Outperform by Oppenheimer, from 11:47AM ET on Wednesday May 15, 2024 by Dow Jones
11:47AM ET on Wednesday May 15, 2024 by Dow Jones
May 14, 2024
DJ Sutro Biopharma Price Target Maintained With a $8.00/Share by Wedbush, from 8:41AM ET on Tuesday May 14, 2024 by Dow Jones
8:41AM ET on Tuesday May 14, 2024 by Dow JonesDJ Sutro Biopharma Price Target Maintained With a $12.00/Share by HC Wainwright & Co., from 7:28AM ET on Tuesday May 14, 2024 by Dow Jones
7:28AM ET on Tuesday May 14, 2024 by Dow Jones
May 13, 2024
Sutro Biopharma Reports First Quarter 2024 Financial Results, Business Highlights and Select Anticipated Milestones, from 4:30PM ET on Monday May 13, 2024 by Dow Jones
4:30PM ET on Monday May 13, 2024 by Dow Jones*DJ Sutro Biopharma 1Q Loss/Shr 95c >STRO, from 4:30PM ET on Monday May 13, 2024 by Dow Jones
4:30PM ET on Monday May 13, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Sutro Biopharma Inc | 345.6M | -2.0x | --- |
Agenus Inc | 329.5M | -1.3x | --- |
Kamada Ltd | 302.9M | 20.1x | -22.48% |
Anika Therapeutics Inc | 380.3M | -5.0x | --- |
Avid Bioservices Inc | 513.6M | -27.8x | --- |
FibroGen Inc | 119.4M | -0.5x | --- |
Company Information
Sutro Biopharma, Inc. is a clinical-stage oncology company. The Company is engaged in developing site-specific and novel-format antibody drug conjugates (ADCs) enabled by its integrated cell-free protein synthesis platform, XpressCF, and its site-specific conjugation platform, XpressCF+. The Company’s advanced product candidate is STRO-002 (luveltamab tazevibulin, or luvelta), an ADC directed against folate receptor-alpha (FolRa), for patients with FolRa-expressing cancers, including ovarian cancer. In addition, it uses luvelta to treat pediatric patients with relapsed/refractory CBFA2T3-GLIS2 and acute myeloid leukemia. It also has two preclinical product candidates, STRO-003 and STRO-004. These product candidates are single homogeneous ADCs directed against an anti-receptor tyrosine kinase-like orphan receptor 1 (ROR1), and tissue factor (TF), each of which is being developed for the treatment of solid tumors.
Contact Information
- Headquarters
- 111 Oyster Point Blvd.SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-392-8412
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Connie Matsui
- President, Chief Operating Officer
- Jane Chung
- Chief Executive Officer, Director
- William Newell
- Chief Financial Officer
- Edward Albini
- Chief People and Communications Officer
- Linda Fitzpatrick
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $345.6M |
|---|---|
Revenue (TTM) | $154.1M |
Shares Outstanding | 81.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.24 |
EPS | $-1.89 |
Book Value | $2.45 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 2.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -67.27% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
